Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (92 total)
-
Créateur: Haddad, Lisa B., Denise J. Jamieson, and Sonja A. Rasmussen.
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2018-12-27
Description: On August 1, 2018, the Ministry of Health of the Democratic Republic of Congo (DRC) reported the emergence of another Ebola virus outbreak, the 10th in the DRC since the virus was discovered in 1976. As of November 13, 2018, there were 341 cases and… -
Créateur: Leshem, Eyal, and Benjamin Alan Lopman.
Sujet: Infection Control
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-23
Description: Vaccines act by two broad main mechanisms. They can block infection occurring entirely or they can halt the progression to symptoms after infection occurs. -
Créateur: Keech, Cheryl, Gary Albert, Iksung Cho, Andreana Robertson, Patricia Reed, Susan Neal, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou, Gale Smith, Nita Patel, Matthew B. Frieman, Robert E. Haupt, James Logue, Marisa McGrath, Stuart…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-12-10
Description: NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike glycoproteins and Matrix-M1 adjuvant. -
Créateur: Scully, Marie, Deepak Singh, Robert Lown, Anthony Poles, Tom Solomon, Marcel Levi, David Goldblatt, Pavel Kotoucek, William Thomas, and William Lester.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-16
Description: The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Within a year, several vaccines have been developed and millions of doses delivered.… -
Créateur: Liu, Yang, Jianying Liu, Hongjie Xia, Xianwen Zhang, Camila R. Fontes-Garfias, Kena A. Swanson, Hui Cai, Ritu Sarkar, Wei Chen, Mark Cutler, David Cooper, Scott C. Weaver, Alexander Muik, Ugur Sahin, Kathrin U. Jansen, Xuping Xie, Philip R.…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-17
Description: BNT162b2 is a nucleoside-modified RNA vaccine expressing the full-length prefusion spike glycoprotein (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a randomized, placebo-controlled clinical trial involving approximately… -
Créateur: Liu, Yang, Jianying Liu, Hongjie Xia, Xianwen Zhang, Camila R. Fontes-Garfias, Kena A. Swanson, Hui Cai, Ritu Sarkar, Wei Chen, Mark Cutler, David Cooper, Scott C. Weaver, Alexander Muik, Ugur Sahin, Kathrin U. Jansen, Xuping Xie, Philip R.…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-08
Description: BNT162b2 is a nucleoside-modified RNA vaccine expressing the full-length prefusion spike glycoprotein (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a randomized, placebo-controlled clinical trial involving approximately… -
Créateur: NETEC
Sujet: Treatment & Care
Type d'élément: Vidéo
Date de la dernière mise à jour: 2022-09-09
Description: In this video, we demonstrate the technique of intradermal medication administration. In the 2022 monkeypox outbreak, this technique is being used to administer the Jynneos smallpox and monkeypox vaccine in order to increase the number of available… -
Créateur: NETEC
Sujet: Emergency Management
Type d'élément: Webinaire
Date de la dernière mise à jour: 2020-12-16
Description: In this webinar, we will discuss the hesitancy surrounding the COVID-19 vaccine including the public fears related to the inconsistencies of risk communication, describe what resources are reliable and available to assist with interpretation of… -
Créateur: Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, Albariño CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, Goff AJ, Spiropoulou CF, Saphire EO, Cavet G, Kawaoka Y, Mehta AK, Glass PJ, Boyd SD,…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-05-30
Description: Ebola virus (EBOV) remains a public health threat. We performed a longitudinal study of B cell responses to EBOV in four survivors of the 2014 West African outbreak. -
Créateur: FDA
Sujet: Treatment & Care
Type d'élément: Guide
Date de la dernière mise à jour: 2022-04
Description: JYNNEOS is a vaccine indicated for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.Includes: indications and usage, dosage and administration, dosage…